Loading
Life sciences · Interventional Study
ClinicalTrials.gov · November 9, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT03153774). This is a study registration, not published results. Lead sponsor: University Hospital, Clermont-Ferrand. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 249 participants (ACTUAL). Conditions: Sarcopenia, Chronic Heart Failure. Interventions: DIAGNOSTIC_TEST: Assessment of sarcopenia prevalence. Primary outcome measures: Bioimpedance analysis data , at day 1; Short physical performance battery , at day 1; Handgrip test , at day 1. Brief summary: The main objective was to assess the prevalence of sarcopenia in chronic heart failure patients and in patients before the trans aortic valvular implantation. The loss of muscle mass in chronic heart failure patients is a prognostic factor for sarcopenia. The purpose was to identify in these patients signs of sarcopenia for a better management.